Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion.

Background: EGFR and ERBB2 exon 20 insertion (Ex20ins) account for a small fraction of patients with EGFR mutations. The efficacy of immune checkpoint inhibitors (ICIs) for these patients was still controversial. Methods: This retrospective study enrolled lung cancer patients harboring either EGFR o...

Full description

Bibliographic Details

Published in:	Current Oncology Vol. 30; no. 11; pp. 9929 - 9940
Main Authors:	Zheng, Yue, Fu, Yang, Chen, Yueyun, Li, Qing, Liu, Ting, Ding, Zhenyu
Format:	Journal Article
Published:	MDPI Nov2023
Online Access:	View this record in EBSCOhost